1. Home
  2. Analysis

Bleeding disorders and drugs of ingredients of sofosbuvir (a real world drug study)


Summary:

Bleeding disorders is found among people who take drugs with ingredients of sofosbuvir, especially for people who are male, 50-59 old , have been taking the drugs for 1 - 6 months. This phase IV clinical study is created by eHealthMe based on reports of 21,826 people who have side effects when taking drugs with ingredients of sofosbuvir from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Sofosbuvir, Sovaldi.

On Jun, 08, 2026

21,826 people reported to have side effects when taking drugs with ingredients of sofosbuvir.
Among them, 20 people (0.09%) have Bleeding disorders

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,200 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

Number of reports submitted per year:

Could drugs with ingredients of sofosbuvir cause Bleeding disorders?

Time on drugs with ingredients of sofosbuvir when people have Bleeding disorders *:

  • < 1 month: 27.27 %
  • 1 - 6 months: 72.73 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Bleeding disorders when taking drugs with ingredients of sofosbuvir *:

  • female: 36.84 %
  • male: 63.16 %

Age of people who have Bleeding disorders when taking drugs with ingredients of sofosbuvir *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.88 %
  • 40-49: 0.0 %
  • 50-59: 70.59 %
  • 60+: 23.53 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Hepatitis C: 8 people, 40.00%
  2. Neuropathy Peripheral (surface nerve damage): 2 people, 10.00%
  3. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 10.00%
  4. Urinary Tract Infection: 1 person, 5.00%
  5. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 5.00%
  6. Hypovolaemia (a decreased volume of circulating blood in the body): 1 person, 5.00%
  7. Hiv Infection: 1 person, 5.00%
  8. Cholecystitis (infection of gallbladder): 1 person, 5.00%
  9. Back Pain: 1 person, 5.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Olysio: 7 people, 35.00%
  2. Truvada: 5 people, 25.00%
  3. Isentress: 5 people, 25.00%
  4. Pantoprazole: 4 people, 20.00%
  5. Eliquis: 4 people, 20.00%
  6. Vicodin: 4 people, 20.00%
  7. Amlodipine: 4 people, 20.00%
  8. Neomycin Sulfate: 2 people, 10.00%
  9. Lasix: 2 people, 10.00%
  10. Oxybutynin: 2 people, 10.00%

Other side effects people have besides Bleeding disorders *:

You may use this to check any potential undetected side effects.

  1. Anaemia (lack of blood): 9 people, 45.00%
  2. Weakness: 7 people, 35.00%
  3. Acute Kidney Failure: 7 people, 35.00%
  4. Septic Shock (shock due to blood infection): 6 people, 30.00%
  5. Multi-Organ Failure (multisystem organ failure): 5 people, 25.00%
  6. Hyperkalemia (damage to or disease of the kidney): 5 people, 25.00%
  7. Thrombocytopenia (decrease of platelets in blood): 5 people, 25.00%
  8. Electrolyte Imbalance: 5 people, 25.00%
  9. Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 4 people, 20.00%
  10. Renal Tubular Necrosis (death of kidney tubules): 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of sofosbuvir, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.